In Simple Terms
In animal and other preclinical studies, going without food for 24 hours changed the gut in ways that seemed to help it recover after radiation. A helpful gut bacterium played an important part, but the findings have not been confirmed in people. They do not show that people with cancer should fast during treatment.
Why Is the Gut Lining a Concern During Radiation Therapy?
Radiation therapy is used to treat cancers in the abdomen, including cancers of the pancreas, colon and rectum, as well as some gynecologic cancers. The treatment directs radiation at cancer cells to damage them, but nearby healthy tissues may also be exposed. That means treatment success depends not only on damaging the tumor, but also on how well the body can tolerate harm to the surrounding tissue.
The small intestine is especially sensitive because its inner surface is lined with a thin layer of cells that acts as a barrier between the contents of the gut and the body’s tissues. Damage to this lining can cause symptoms such as nausea, diarrhea and infection. In severe cases, complications can be life-threatening, making intestinal injury more than a source of temporary discomfort.
The risk of harming healthy tissue can also limit how much radiation doctors can safely use. That is why researchers are looking for ways to protect normal tissue or help it repair itself faster, without compromising the main goal of treatment: controlling the cancer. The new study focuses on one part of that challenge—whether intestinal cells can be prepared before injury so they respond better afterward.
A Clue from Earlier Research Raises a New Question
In earlier preclinical work, Helen Bionica-Worms’s laboratory observed that fasting before radiation exposure was associated with better intestinal recovery afterward. But observing a protective effect does not reveal what is happening inside the body or which factors are essential for that effect. The unanswered question was how going without food might leave tissue cells better prepared to respond.
In the newer study, the researchers found that a 24-hour fast increased the abundance of a beneficial bacterium called Akkermansia muciniphila, or AKK, in the small intestine. The change may matter for more than the increase in the bacterium’s numbers: these microbes produce a substance called propionate, which the study linked to signals that help intestinal cells activate programs involved in tissue renewal.
The findings do not suggest that fasting acts as a direct switch for tissue repair. Instead, they point to a chain of interacting events. Changes in food intake occur alongside metabolic shifts and an increase in a particular bacterium; substances produced by the bacterium then take part in a process that affects how prepared cells are to respond. This makes the relationship between diet, microbes and tissue renewal more complex than the idea that eating less alone explains the protection.
How Does the Signal Prepare a Cell?
One step identified by the researchers involves histones, proteins that DNA is wrapped around inside a cell. Histones can carry small chemical marks that affect how easily a cell can access different parts of its genetic material. This does not mean the DNA sequence itself changes. Rather, some genes may become easier to reach, increasing the chances that the cell will switch them on or regulate their activity.
According to the study, propionate works alongside other metabolic changes associated with fasting to alter these marks on histones. The changes make some regions of DNA more accessible, helping cells activate genes linked to tissue renewal. One way to picture this is as a set of instructions stored inside the cell: the DNA is not rewritten, but some pages become easier to open and read when the cell needs to respond.
The team also observed that a group of intestinal cells carrying these repair-related programs increased during fasting. That matters because the preparation appears to involve more than a quick change in the cells’ surroundings; it is associated with the emergence of a cellular state that is better prepared to act. When the intestine is later exposed to radiation, these cells can multiply and help rebuild the damaged lining.
It is important to distinguish being prepared to repair damage from being protected against injury altogether. Radiation can still cause harm, and the findings describe a biological response that may help tissue recover—not a shield that stops radiation from reaching it. The researchers do not claim that the mechanism eliminates symptoms or prevents every complication. It offers a possible explanation for improved regenerative capacity under the conditions studied.
Tests Showed the Bacterium Was More Than a Side Detail
To test AKK’s role, the researchers did more than measure how abundant it was: they selectively removed the bacterium and examined what happened. When it was absent, fasting no longer produced the same regenerative benefit in the intestine. This links the bacterium to the response, but does not prove that every effect of fasting depends on AKK alone; the study also points to the involvement of other metabolic changes.
A restoration test added an important piece of evidence. The protective response returned when the bacterium was introduced again alongside fasting. Neither the bacterium alone nor fasting alone was enough to reproduce the full response seen when they were combined. This suggests that the two work in a shared context, and that the effect of either one cannot simply be assumed in isolation.
This comparison shows why an increase in a particular microbe is not, by itself, enough to establish that the microbe caused an improvement. Its presence after fasting could be a coincidence unless researchers test what happens when it is removed and then restored. Through these experiments, the study provided evidence that AKK is an essential part of the observed response, while leaving open questions about how the bacterium, its products and intestinal cells interact.
From Preclinical Findings to a Possible Treatment
The findings are still preclinical, so they cannot be translated directly into advice for patients. The study does not show that a 24-hour fast protects the human intestine during radiation therapy, or establish whether fasting would be safe or appropriate for different patients. Cancer treatment can also create specific health and nutritional needs, so a research finding should not be treated as personal advice to fast.
Still, the pathway uncovered in the study opens up possibilities beyond going without food. The researchers believe that understanding the roles of the bacterium and the substances it produces could eventually help activate similar repair mechanisms through other approaches. Options for future research include beneficial microbes or the molecules they produce, as well as carefully considered dietary interventions. None of these approaches should be assumed to be a proven treatment.
These alternatives are worth exploring because fasting is not a practical option for every person with cancer. A method that targets a substance produced by the bacterium, or the related signal inside cells, might be more feasible than asking patients to avoid food. But getting there will first require determining whether the mechanism works the same way in people, and what doses or conditions might be safe and effective, if any.
Scientists are also considering whether mechanisms like this could help other healthy tissues damaged by cancer treatments. Bone marrow is one tissue of interest because it contains rapidly dividing cells that can be affected by treatment. But this remains a possibility for future research, not a finding established by the current study, which focused on the readiness of intestinal cells to regenerate after radiation injury.
What Must Future Research Establish?
The next step is to determine how well the findings apply to people, then assess whether changing this pathway can actually reduce tissue damage without interfering with treatment of the tumor. Future studies will need to examine both safety and effectiveness. Protecting healthy tissue is important, but that protection would not be useful if it conflicted with the demands of cancer treatment.
Researchers will also need to identify which parts of the chain are most promising to target. Does the benefit depend on AKK itself, on the propionate it produces, or on the way the bacterium interacts with metabolic changes caused by fasting? How much does each step contribute to activating repair programs? Answering these questions could help researchers move from describing a combined effect to designing a specific intervention that can be tested precisely.
The study was co-led by Helen Bionica-Worms, a professor of experimental radiation oncology, and Kunal Rai, a professor of genomic medicine. The findings were published in the journal Proceedings of the National Academy of Sciences. The research was funded by the National Cancer Institute, part of the National Institutes of Health, and the Cancer Prevention and Research Institute of Texas. The work lays the groundwork for new questions about the connections among diet, microbes and tissue renewal, but it does not yet show how to turn the findings into clinical care.
The Bottom Line
The study points to a possible link between a 24-hour fast, an increase in AKK bacteria in the small intestine and cellular changes that help prepare the intestinal lining to rebuild after radiation damage. The bacterium and the substances it produces appear to contribute, alongside other changes associated with fasting, by affecting gene activity without changing the DNA sequence. The findings could help researchers understand how to protect healthy tissue during cancer treatment, but they are still preclinical: they do not establish that fasting benefits patients or justify recommending it. In the future, targeting the bacterium or its products may prove more practical—but only after the approach has been tested for safety and effectiveness in people.